These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34737241)

  • 1. Diffusion Measure Changes of Substantia Nigra Subregions and the Ventral Tegmental Area in Newly Diagnosed Parkinson's Disease.
    Shim JH; Baek HM
    Exp Neurobiol; 2021 Oct; 30(5):365-373. PubMed ID: 34737241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting dopaminergic neuronal degeneration using diffusion tensor imaging in a rotenone-induced rat model of Parkinson's disease: fractional anisotropy and mean diffusivity values.
    Liu LX; Du D; Zheng T; Fang Y; Chen YS; Yi HL; He QY; Gao DW; Shi QL
    Neural Regen Res; 2017 Sep; 12(9):1485-1491. PubMed ID: 29089995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
    Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
    Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nigral diffusivity, but not free water, correlates with iron content in Parkinson's disease.
    Langley J; Huddleston DE; Hu X
    Brain Commun; 2021; 3(4):fcab251. PubMed ID: 34805996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.
    Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP
    Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease.
    Zhang Y; Wu IW; Buckley S; Coffey CS; Foster E; Mendick S; Seibyl J; Schuff N
    Mov Disord; 2015 Aug; 30(9):1229-36. PubMed ID: 25920732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel method for evaluating brain function and microstructural changes in Parkinson's disease.
    Jiang MF; Shi F; Niu GM; Xie SH; Yu SY
    Neural Regen Res; 2015 Dec; 10(12):2025-32. PubMed ID: 26889194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.
    Du G; Lewis MM; Styner M; Shaffer ML; Sen S; Yang QX; Huang X
    Mov Disord; 2011 Aug; 26(9):1627-32. PubMed ID: 21618607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-High Field MRI Post Mortem Structural Connectivity of the Human Subthalamic Nucleus, Substantia Nigra, and Globus Pallidus.
    Plantinga BR; Roebroeck A; Kemper VG; Uludağ K; Melse M; Mai J; Kuijf ML; Herrler A; Jahanshahi A; Ter Haar Romeny BM; Temel Y
    Front Neuroanat; 2016; 10():66. PubMed ID: 27378864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Assessment of Diffusion Parameters and Cerebral Blood Flow Within Basal Ganglia in Early Parkinson's Disease.
    Pelizzari L; Laganà MM; Di Tella S; Rossetto F; Bergsland N; Nemni R; Clerici M; Baglio F
    Front Aging Neurosci; 2019; 11():134. PubMed ID: 31214017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping tracts in the human subthalamic area by 11.7T ex vivo diffusion tensor imaging.
    Oishi K; Mori S; Troncoso JC; Lenz FA
    Brain Struct Funct; 2020 May; 225(4):1293-1312. PubMed ID: 32303844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microstructural Changes within the Basal Ganglia Differ between Parkinson Disease Subtypes.
    Nagae LM; Honce JM; Tanabe J; Shelton E; Sillau SH; Berman BD
    Front Neuroanat; 2016; 10():17. PubMed ID: 26941615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD).
    Esterhammer R; Seppi K; Reiter E; Pinter B; Mueller C; Kremser C; Zitzelsberger T; Nocker M; Scherfler C; Poewe W; Schocke M
    PLoS One; 2015; 10(12):e0145493. PubMed ID: 26713760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
    Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
    PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.
    Schwarz ST; Abaei M; Gontu V; Morgan PS; Bajaj N; Auer DP
    Neuroimage Clin; 2013; 3():481-8. PubMed ID: 24273730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional changes of the basal ganglia circuitry in Parkinson's disease.
    Blandini F; Nappi G; Tassorelli C; Martignoni E
    Prog Neurobiol; 2000 Sep; 62(1):63-88. PubMed ID: 10821982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease.
    Rolheiser TM; Fulton HG; Good KP; Fisk JD; McKelvey JR; Scherfler C; Khan NM; Leslie RA; Robertson HA
    J Neurol; 2011 Jul; 258(7):1254-60. PubMed ID: 21287185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.